mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
-0.0073 |
0.9 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.045 |
0.9 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |